| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9961 | 
      | Human Intestinal Absorption | HIA- | 0.9470 | 
      | Caco-2 Permeability | Caco2- | 0.8171 | 
      | P-glycoprotein Substrate | Substrate | 0.7143 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9153 | 
                                                     | Non-inhibitor | 0.9970 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9488 | 
        
            | Distribution | 
        
      | Subcellular localization | Lysosome | 0.5282 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8429 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8250 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5000 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8594 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9839 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9994 | 
                                                                    | Non-inhibitor | 0.8895 | 
      | AMES Toxicity | Non AMES toxic | 0.8339 | 
      | Carcinogens | Non-carcinogens | 0.8335 | 
      | Fish Toxicity | High FHMT | 0.9765 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.6180 | 
      | Honey Bee Toxicity | Low HBT | 0.7233 | 
      | Biodegradation | Not ready biodegradable | 0.9667 | 
      | Acute Oral Toxicity | IV | 0.6146 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6707 |